EP3227447

AGILENT TECHNOLOGIES, INC.
Application Number
EP15866342A
Filing Date
Dec 3, 2015
Status
Granted And Under Opposition
Mar 22, 2024
Grant Date
Apr 24, 2024
External Links
Slate, Register

Biblio Summary

The patent EP3227447B1 was granted on Apr 24, 2024 by Agilent Technologies, Inc. The patent is currently Granted And Under Opposition.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLE LIMITEDSep 23, 2024 N.A.

The table below shows the patents of Agilent Technologies, Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3280803Chemically Modified Guide Rnas For Crispr/Cas-Mediated Gene RegulationMay 26, 20213
EP2524036Thermostable Type-A Dna Polymerase Mutants With Increased Polymerization Rate And Resistance To InhibitorsJun 12, 20191
EP2737379Packet-Wise Proportioning Followed By Immediate Longitudinal MixingDec 19, 20181

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.